Eosinophilic fasciitis in a pediatric patient

Journal of Clinical Rheumatology

Volumn 16, Issue 3, 2010, Pages 129-131

  Loupasakis, Konstantinos ^a   Derk, Chris T ^b  

^a ST ELIZABETH'S MEDICAL CENTER   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Eosinophilic fasciitis; Fasciitis; Fibrosis; Mycophenolate mofetil; Scleroderma; Treatment

Indexed keywords

GADOLINIUM; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE;

ABSENCE OF SIDE EFFECTS; ARTICLE; CASE REPORT; CHILD; CLINICAL ASSESSMENT; CUSHINGOID SYNDROME; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; EOSINOPHILIC FASCIITIS; ERYTHEMA; HUMAN; HUMAN TISSUE; JOINT CONTRACTURE; MALE; MUSCLE BIOPSY; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSIOTHERAPY; PRIORITY JOURNAL; SCHOOL CHILD; SKIN BIOPSY; SKIN EXAMINATION; SKIN INDURATION; SYSTEMIC SCLEROSIS; TREATMENT DURATION;

ADRENAL CORTEX HORMONES; ANTI-INFLAMMATORY AGENTS; CHILD; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; EOSINOPHILIA; FASCIITIS; HUMANS; MALE; MYCOPHENOLIC ACID;

EID: 77951073506     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/RHU.0b013e3181d56f73     Document Type: Article

References (50)

1. Shulman LE. Diffuse fasciitis with hypergammaglobulinemia and eosinophilia: a new syndrome? J Rheumatol. 1984;11:569-570.
2. Rodnan GP, DiBartolomeo AG, Medsger TA. Eosinophilic fasciitis. Report of 7 cases of a newly recognized scleroderma-like syndrome. Arthritis Rheum. 1975;18:422-423.
3. Balat A, Akinci A, Turgut M, et al. Eosinophilic fasciitis-progression to linear scleroderma: a case report. Turk J Pediatr. 1999;41:381-385.
4. Peterson LS, Nelson AM, Su WP. Classification of morphea (localized scleroderma). Mayo Clin Proc. 1995;70:1068-1076.
5. Antic M, Lautenschlager S, Itin PH. Eosinophilic fasciitis 30 years after- what do we really know? Report of 11 patients and review of the literature. Dermatol. 2006;213:93-101.
6. Helfman T, Falanga V. Eosinophilic fasciitis. Clin Dermatol. 1994;12:449-455.
7. Barnes L, Rodnan GP, Medsger TA, et al. Eosinophilic fasciitis. Am J Pathol. 1979;96:493-507.
8. Blaser KU, Steiger U, Wursch A, et al. Eosinophilic fasciitis with aplastic anemia and Hashimoto's thyroiditis: review of the literature and report of a typical example. Schweiz Med Wochenschr. 1989;119:1899-1906.
9. Ortega-Loayza AG, Merritt BG, Groben PA, et al. Eosinophilic fasciitis in a female child. J Am Acad Dermatol. 2008;58(suppl 1):S72-S74.
10. Black CM. Scleroderma and fasciitis in children. Curr Opin Rheumatol. 1995;7:442-448.
11. Grisanti MW, Moore TL, Osborn TG, et al. Eosinophilic fasciitis in children. Semin Arthritis Rheum. 1989;19:151-157.
12. Pillen S, van Engelen B, van den Hoogen F, et al. Eosinophilic fasciitis in a child mimicking a myopathy. Neuromuscul Disord. 2006;16:144-148.
13. Huppke P, Wilken B, Brockmann K, et al. Eosinophilic fasciitis leading to painless contractures. Eur J Pediatr. 2002;161:528-530.
14. Jacobs JC. Eosinophilic fasciitis, In: Katz M, Stiehm ER, eds. Pediatric Rheumatology. New York, NY: Springer-Verlag; 1982:504-507.
15. Kaplinsky N, Bubis JJ, Pras M. Localized eosinophilic fasciitis in a child. J Rheumatol. 1980;7:541-543.
16. Stork J, Němcová D, Hoza J, et al. Eosinophilic fasciitis in an adolescent girl with lymphadenopathy and vitiligo-like and linear scleroderma-like changes. A case report. Clin Exp Rheumatol. 1996;14:337-341.
17. Ching DW, Petrie JP. Childhood eosinophilic fasciitis presenting as inflammatory polyarthritis and associated with selective IgA deficiency. Ann Rheum Dis. 1991;50:647-648.
18. De Jonge-Bok JM, Steven MM, Eulderink F, et al. Diffuse (eosinophilic) fasciitis. A series of six cases. Clin Rheumatol. 1984;3:365-373.
19. Dziadzio L, Kelly EA, Panzer SE, et al. Cytokine abnormalities in a patient with eosinophilic fasciitis. Ann Allergy Asthma Immunol. 2003;90:452-455.
20. Lakhanpal S, Ginsburg WW, Michet CJ, et al. Eosinophilic fasciitis: clinical spectrum and therapeutic response in 52 cases. Semin Arthritis Rheum. 1988;17:221-231.
21. Clauw DJ, Crofford LJ. Eosinophilic rheumatic disorders. Rheum Dis Clin North Am. 1995;21:231-246.
22. Fujimoto M, Sato S, Ihn H, et al. Serum aldolase level is a useful indicator of disease activity in eosinophilic fasciitis. J Rheumatol. 1995;22:563-565.
23. Al-Shaikh A, Freeman C, Avruch L, et al. Use of magnetic resonance imaging in diagnosing eosinophilic fasciitis. Arthritis Rheum. 1994;37:1602-1608.
24. Farrington ML, Haas JE, Nazar-Stewart V, et al. Eosinophilic fasciitis in children frequently progresses to scleroderma- like cutaneous fibrosis. J Rheumatol. 1993;20:128-132.
25. Williams HJ, Ziter FA, Banta CA. Childhood eosinophilic fasciitis-progression to linear scleroderma. J Rheumatol. 1986;13:961-962.
26. Michet CJ Jr, Doyle JA, Ginsburg WW. Eosinophilic fasciitis. Mayo Clin Proc. 1981;56:27-34.
27. Lewis RB, van Valkenburg WB. Eosinophilic fasciitis. Ann Intern Med. 1978;88:577-588.
28. Kent LT, Cramer SF, Moskowitz RW. Eosinophilic fasciitis: clinical, laboratory, and microscopic considerations. Arthritis Rheum. 1981;24:677-683.
29. Allen SC. Eosinophilic fasciitis in an African-possible benefit of chloroquine treatment. Postgrad Med J. 1984;60:685-686.
30. Huemer M, Seeber A, Huemer C. Scleroderma-like syndrome in a child: eosinophilic fasciitis or scleredema adultorum? Eur J Pediatr. 2000;159:520-522.
31. Quintero-Del-Rio AI, Punaro M, Pascual V. Faces of eosinophilic fasciitis in childhood. J Clin Rheumatol. 2002;8:99-103.
32. Falanga V, Soter NA, Kerdel FA. Increased plasma histamine level in eosinophilic fasciitis. Arch Dermatol. 1989;125:805-808.
33. Gabrielli A, De Nictolis M, Campanati G, et al. Eosinophilic fasciitis: a mast cell disorder? Clin Exp Rheumatol. 1983;1:75-80.
34. Naschitz JE, Yeshurun D, Rosner I, et al. Treatment with cimetidine of atypical fasciitis panniculitis syndrome. Ann Rheum Dis. 1990;49:788-792.
35. Loftin EB. Cimetidine and eosinophilic fasciitis. Ann Intern Med. 1983;98: 111-112.
36. Laso FJ, Pastor J, De Castro S. Cimetidine and eosinophilic fasciitis. Ann Intern Med. 1983;98:1026.
37. Garcia-Morteo O, Maldonado-Cocco JA, Barreira JC, et al. Cimetidine and eosinophilic fasciitis. Ann Intern Med. 1984;100:318-319.
38. Ristic B, Zecevic RD, Karadaglic Dj. Treatment of eosinophilic fasciitis with cimetidine. Vojnosanit Pregl. 2001;58:437-440.
39. Jiménez Martínez A, Jorda Cuevas E, Ramón Quiles D, et al. Eosinophilic fasciitis. Response to treatment with cimetidine [in Spanish]. Med Cutan Ibero Lat Am. 1987;15:81-83.
40. Solomon G, Barland P, Rifkin H. Eosinophilic fasciitis responsive to cimetidine. Ann Intern Med. 1982;97:547-549.
41. Uçkun A, Sipahi T, Akgün D, et al. Eosinophilic fasciitis successfully treated with oral hydroxyzine: a new therapeutic use of an old drug? Eur J Pediatr. 2002;161:118-119.
42. Scharffetter-Kochanek K, Goldermann R, Lehmann P, et al. PUVA therapy in disabling pansclerotic morphoea of children. Br J Dermatol. 1995;132:830-831.
43. Horacek E, Sator PG, Gschnait F. 'Venous furrowing': a clue to the diagnosis of eosinophilic fasciitis. A case of eosinophilic fasciitis ultimately treated with oral PUVA therapy. Dermatology. 2007;215:89-90.
44. Schiener R, Behrens-Williams SC, Gottlöber P, et al. Eosinophilic fasciitis treated with psoralen-ultraviolet A bath photochemotherapy. Br J Dermatol. 2000;142:804-807.
45. Drosou A, Kirsner RS, Welsh E, et al. Use of infliximab, an anti-tumor necrosis alpha antibody, for inflammatory dermatoses. J Cutan Med Surg. 2003;7:382-386.
46. Alexis AF, Strober BE. Off-label dermatologic uses of anti-TNF-a therapies. J Cutan Med Surg. 2005;9:296-302.
47. Tzaribachev N, Holzer U, Schedel J, et al. Infliximab effective in steroiddependent juvenile eosinophilic fasciitis. Rheumatology (Oxford). 2008;47: 930-932.
48. Scheinberg M, Hamerschlak N, Kutner JM, et al. Rituximab in refractory autoimmune diseases: Brazilian experience with 29 patients (2002-2004). Clin Exp Rheumatol. 2006;24:65-69.
49. Bischoff L, Derk CT. Eosinophilic fasciitis: demographics, disease pattern and response to treatment: report of 12 cases and review of the literature. Int J Dermatol. 2008;47:29-35.
50. Shenin M, Naik M, Derk CT. The use of mycophenolate mofetil for the treatment of systemic sclerosis. Endocr Metab Immune Disord Drug Targets. 2008;8:11-14.